ACTL8 and neoplasm: ACTL8-knockdown inhibits lung cancer cell proliferation, colony formation, cell cycle progression, migration and invasion, and lung cancer cell A549 tumour growth in vivo, indicating that it exerts an oncogenic role in lung cancer cell tumorigenesis and progression (47).